World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

Chapter 4: R&D Management in the Japanese Pharmaceutical Industry

    https://doi.org/10.1142/9789811204692_0004Cited by:0 (Source: Crossref)
    Abstract:

    We analyze how Japanese pharmaceutical firms internationalized their research and development (R&D) investments during the 1980s and 1990s. In order to tap into foreign knowledge bases, they heavily invested in setting up R&D canters abroad. However, knowledge transfer, evidenced by international patent applications, was very limited during the early phase of globalization. As a response, Japanese firms have shifted their R&D strategy toward a better organizational integration of their foreign units.